According to Hims & Hers Health's latest financial reports the company has a price-to-book ratio of 4.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 4.27 | 7.02% |
2021-12-31 | 3.99 | |
2020-12-31 | N/A | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | 1.01 | -74.94% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | 1.53 | -62.22% | ๐ฌ๐ง UK |
![]() Novavax NVAX | -0.9916 | -124.50% | ๐บ๐ธ USA |
![]() Novocure
NVCR | 4.47 | 10.31% | Jersey |